Amebiasis Annual Report 2017

Total Page:16

File Type:pdf, Size:1020Kb

Amebiasis Annual Report 2017 Amebiasis Annual Report 2017 Amebiasis Amebiasis is no longer a reportable disease in Louisiana. Outbreaks, however, should still be reported. Amebiasis (amoebiasis) is a parasitic infection caused by Entamoeba histolytica or Entamoeba dispar. The parasite is transmitted by the fecal-oral route, either through direct contact with feces or through the consumption of contaminated food or water. Between 80% and 90% of infected individuals develop no symptoms. For symptomatic cases, the incubation period between infection and illness can range from days to weeks. The symptoms are typically gastrointestinal issues, such as diarrhea or stomach pains. It is also possible for the parasite to spread to the liver and cause abscesses. Entamoeba histolytica can be found world-wide, but is more prevalent in tropical regions with poor sanitary conditions. In some areas with extremely adverse conditions, the prevalence can be as high as 50% in the population. There are no recent data on prevalence of amebiasis in the U.S. however, prevalence is estimated to be between 1% and 4% of the population. High risk groups are refugees, recent immigrants, travelers (particularly those who have spent long periods of time in an endemic area), institutionalized people (particularly developmentally or mentally-impaired people), and men who have sex with men. The number of cases reported within Louisiana is usually low. There are typically less than ten cases per year with a few exceptions (Figure 1). Figure 1: Amebiasis cases - Louisiana, 1970-2017 40 35 30 25 20 15 Number of Cases Number 10 5 0 70 72 74 76 78 80 82 84 86 88 90 92 94 96 98 00 02 04 06 08 10 12 14 16 Year Louisiana Office of Public Health – Infectious Disease Epidemiology Section Page 1 of 4 Amebiasis Annual Report 2017 Hospitalization Hospitalization surveillance is based on Louisiana Hospital Inpatient Discharge Data (LaHIDD). In 1997, the Louisiana legislature mandated the reporting of hospital discharge data. LaHIDD serves as the state registry for hospital discharge data submitted to the Louisiana Department of Health (LDH). The Office of Public Health (OPH) is responsible for providing the data to OPH sections as needed. The Infectious Disease Epidemiology Section uses these data sets for surveillance of infectious diseases in hospitals. The data is available after a delay of two years. LaHIDD data sets contain demographic information (names, gender, age, date of birth, address), admit diagnosis, discharge diagnoses (main diagnosis plus eight additional diagnoses), procedures (main plus five), charges, length of stay and hospital name. The diagnoses and procedures are coded with ICD-9 codes. Repeat hospitalizations are not included in the analysis. Records of patients with amebiasis were extracted using the following ICD-9 codes, whether the code was identified in the main diagnosis or in the eight additional secondary diagnoses: CODE DISEASE 006 Amebiasis 006.0 Acute Amebic Dysentary without mention of abscess 006.1 Chronic Intestinal Amebiasis without mention of abscess 006.2 Amebic Nondysenteric Colitis 006.3 Amebic Liver Abscess 006.4 Amebic Lung Abscess 006.5 Amebic Brain Abscess 006.6 Amebic Skin Ulceration 006.8 Amebic Infection of other sites 006.9 Amebiasis, unspecified Hospitalization Numbers, Rates and Trends The following statistics are based on de-duplicated patient records. For the entire period, the hospitalization rate was 0.10 per 100,000 population; rates ranged from 0.02 to 0.18 per 100,000 population. The number of hospitalizations ranged from one to eight per year (Figure 2). Louisiana Office of Public Health – Infectious Disease Epidemiology Section Page 2 of 4 Amebiasis Annual Report 2017 Figure 2: Amebiasis hospitalizations – Louisiana, 1999-2014 9 8 7 6 5 4 3 2 Number of Hospitalizations Number 1 0 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 Year Hospitalization rates due to amebiasis have been steady since 2008. Peak hospitalization rates were seen in 2000 (0.18 per 100,000). The lowest hospitalization rates occurred in 2014, (0.02 per 100,000). The regression line shows that the slope of the decreasing rate is 0.0051 per 100,000 population per year (Figure 3). Figure 3: Rate of amebiasis hospitalizations per 100,000 population - Louisiana, 1999-2014 0.2 0.18 y = -0.0051x + 0.1509 0.16 0.14 0.12 0.1 0.08 Population 0.06 0.04 0.02 Hospitalization Rate per 100,000 per Rate Hospitalization 0 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 Year Gender The trends in hospitalization by gender have been variable in the years 1999 to 2014. The overall rate of amebiasis hospitalization was 0.15 per 100,000 for males and 0.07 per 100,000 for females. Currently, based on trend lines, male hospitalization rates for amebiasis are decreasing and rates for females remain steady (Figure 4). Louisiana Office of Public Health – Infectious Disease Epidemiology Section Page 3 of 4 Amebiasis Annual Report 2017 Figure 4: Hospital rates for amebiasis by gender – Louisiana, 1999-2014 0.40 Male Female 0.35 0.30 0.25 0.20 Population 0.15 0.10 0.05 Hospitalization Rate per 100,000 per Rate Hospitalization 0.00 99 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 Year Race Rates were not calculated due to the small number of cases and high proportions of unknown. Age Group Amebiasis generally targets those individuals who live in tropical areas with poor sanitary conditions, although anyone can acquire this disease. Rates by age group were very low, showing no major differences by age group: zero per 100,000 in children (age group newborn to 14 years), 0.07 per 100,000 in older children and adults (age group 15 to 64 years), and 0.19 per 100,000 in the elderly (age group 65 years and older). Seasonality Seasonal variation has been recorded in tropical areas overseas where amebiasis is more prevalent. However, this seasonal component generally reflected water shortages where the consumption of contaminated water became more prevalent. Consistent with the United States, Louisiana’s cumulative data for the years 1999 to 2010 show that amebiasis hospitalization rates are not influenced by season. Clinical data Most cases are intestinal (75%). Twenty-three percent (23%) of the cases reported liver abscesses and only one case reported a lung abscess. Mortality There was one death attributed to amebiasis in 2000. Louisiana Office of Public Health – Infectious Disease Epidemiology Section Page 4 of 4 .
Recommended publications
  • An Unusual Case of Amoebic Liver Abscess Presenting with Hepatic Encephalopathy: a Case Report
    Case Report An Unusual Case of Amoebic Liver Abscess Presenting with Hepatic Encephalopathy: A Case Report Anil Kumar SARDA, Rakesh MITTAL Submitted: 16 Sep 2010 Department of Surgery, Maulana Azad Medical College and Lok Nayak Accepted: 3 Jan 2011 Hospital, New Delhi 110 002, India Abstract Amoebic liver abscess (ALA) with jaundice and encephalopathy is a rare occurrence and has been recognised and studied more frequently in recent years. We present a case of massive ALA presenting with jaundice, hepatic encephalopathy, and septicaemia that was treated successfully with percutaneous drainage of the abscess, right-sided chest tube insertion, and anti-amoebic therapy. Keywords: amoebiasis, hepatic encephalopathy, hepatology, jaundice, liver abscess Introduction On chest examination, there was bilateral equal air entry. Upon investigation, haemoglobin was Amoebic liver abscess (ALA) is the most 11 g/dL, with a total leukocyte count of frequent extra-intestinal manifestation of 13 000 cells/mm3 (normal range is 4000– Entamoeba histolytica infection. It has been 11 000 cells/mm3). Liver function tests revealed reported that jaundice is uncommon and mild total serum bilirubin of 20 mg/dL, with direct in liver abscess, and some even consider the bilirubin of 15 mg/dL, serum glutamic-oxaloacetic presence of jaundice as a feature against the transaminase (SGOT) of 324 IU/L (normal level diagnosis of hepatic amoebiasis (1). The cause of is less than 40 IU/L), serum glutamic–pyruvic jaundice in a case of ALA has been hypothesised transaminase (SGPT) of 340 IU/L (normal level to result from either hepatocellular dysfunction or is less than 40 IU/L), and alkaline phosphatase intrahepatic biliary obstruction (2).
    [Show full text]
  • Surveillance Study of Acute Gastroenteritis Etiologies in Hospitalized Children in South Lebanon (SAGE Study)
    pISSN: 2234-8646 eISSN: 2234-8840 https://doi.org/10.5223/pghn.2018.21.3.176 Pediatr Gastroenterol Hepatol Nutr 2018 July 21(3):176-183 Original Article PGHN Surveillance Study of Acute Gastroenteritis Etiologies in Hospitalized Children in South Lebanon (SAGE study) Ghassan Ghssein, Ali Salami, Lamis Salloum, Pia Chedid*, Wissam H Joumaa, and Hadi Fakih† Rammal Hassan Rammal Research Laboratory, Physio-toxicity (PhyTox) Research Group, Lebanese University, Faculty of Sciences (V), Nabatieh, *Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Balamand, †Department of Pediatrics, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon Purpose: Acute gastroenteritis (AGE) is a major cause of morbidity and remains a major cause of hospitalization. Following the Syrian refugee crisis and insufficient clean water in the region, this study reviews the etiological and epidemiological data in Lebanon. Methods: We prospectively analyzed demographic, clinical and routine laboratory data of 198 children from the age of 1 month to 10 years old who were admitted with the diagnosis of AGE to a private tertiary care hospital located in the district of Nabatieh in south Lebanon. Results: Males had a higher incidence of AGE (57.1%). Pathogens were detected in 57.6% (n=114) of admitted pa- tients, among them single pathogens were found in 51.0% (n=101) of cases that consisted of: Entamoeba histolytica 26.3% (n=52), rotavirus 18.7% (n=37), adenovirus 6.1% (n=12) and mixed co-pathogens found in 6.6% (n=13). Breast-fed children were significantly less prone to rotavirus (p=0.041). Moreover, children who had received the rota- virus vaccine were significantly less prone to rotavirus (p=0.032).
    [Show full text]
  • Amoebic Colitis Presenting As Subacute Intestinal Obstruction with Perforation
    International Journal of TROPICAL DISEASE & Health 41(16): 58-62, 2020; Article no.IJTDH.61831 ISSN: 2278–1005, NLM ID: 101632866 Amoebic Colitis Presenting as Subacute Intestinal Obstruction with Perforation Renuka Verma1, Archana Budhwar1*, Priyanka Rawat1, Niti Dalal1, Anjali Bishlay1 and Sunita Singh1 1Pt. B. D. Sharma Post Graduate Institute of Medical Sciences, Rohtak-124001, Haryana, India. Authors’ contributions This work was carried out in collaboration among all authors. Authors RV and SS designed the study, reviewed the manuscript and edited it. Author Archana Budhwar wrote the protocol and wrote the first draft of the manuscript. Author PR managed the literature searches. Authors ND and Anjali Bishlay managed the analyses of the study. All authors read and approved the final manuscript. Article Information DOI: 10.9734/IJTDH/2020/v41i1630367 Editor(s): (1) Dr. Giuseppe Murdaca, University of Genoa, Italy. Reviewers: (1) Ammar M. Al-Aalim, Mosul University, Iraq. (2) Tarunbir Singh, Guru Angad Dev Veterinary & Animal Sciences University, Ludhiana. Complete Peer review History: http://www.sdiarticle4.com/review-history/61831 Received 10 August 2020 Case Study Accepted 16 October 2020 Published 12 November 2020 ABSTRACT Infestation with Entamoeba histolytica is worldwide, especially in developing areas. Presented case study included amoebic colitis in a 45 years old man complaining of abdominal distension and non- passage of stools since three days. Abdominal region was diffusely distended and tender in right iliac fossa. Plain abdominal radiography revealed prominent gut loops and minimal intergut free fluid. At laparotomy, malrotation of gut was present. Histopathological examination of intestinal samples confirmed final diagnosis of amoebic colitis post-operatively.
    [Show full text]
  • Improved Genomic Assembly and Genomic Analyses of Entamoeba Histolytica
    Improved genomic assembly and genomic analyses of Entamoeba histolytica Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Amber Leckenby September 2018 Acknowledgements There are many people without whom this thesis would not have been possible. The list is long and I am truly grateful to each and every one. Firstly I have to thank my supervisors Gareth, Christiane, Neil and Steve for the continuous support throughout my PhD. Particularly, I am grateful to Gareth and Christiane, for their patience, motivation and immense knowledge that helped me through the entirety of the proJect from the initial research to the writing of this thesis. I cannot have imagined having better mentors and role models. I also have to thank the staff at the CGR for their role in the sequencing aspects of this thesis. My further thanks extend to the CGR bioinformatics team, most notably Richard, Matthew, Sam and Luca, for not only tolerating the number of bioinformatics questions I have asked them, but also providing great friendship and warmth in the office. I must also give a special mention to Graham Clark at the London School of Hygiene and Tropical Medicine for sending cultures of Entamoeba and providing general advice, especially around the tRNA arrays. I would also like to thank David Starns, for his efforts troubleshooting the Companion pipeline and to Laura Gardiner for providing advice around all things methylation. My gratitude goes to the members of the many offices I have moved around during my PhD, many of which have become close friends who have got me through many bioinformatics conundrums, lab meltdowns and (some equally challenging) gym sessions.
    [Show full text]
  • Granulomatous Meningoencephalitis Balamuthia Mandrillaris in Peru: Infection of the Skin and Central Nervous System
    SMGr up Granulomatous Meningoencephalitis Balamuthia mandrillaris in Peru: Infection of the Skin and Central Nervous System A. Martín Cabello-Vílchez MSc, PhD* Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical “Alexander von Humboldt” *Corresponding author: Instituto de Medicina Tropical “Alexander von Humboldt”, Av. Honorio Delgado Nº430, San A. Martín Cabello-Vílchez, Universidad Peruana Cayetano Heredia, MartínPublished de Porras, Date: Lima-Perú, Tel: +511 989767619, Email: [email protected] February 16, 2017 ABSTRACT Balamuthia mandrillaris is an emerging cause of sub acute granulomatous amebic encephalitis (GAE) or Balamuthia mandrillaris amoebic infection (BMAI). It is an emerging pathogen causing skin lesions as well as CNS involvement with a fatal outcome if untreated. The infection has been described more commonly in inmunocompetent individuals, mostly males, many children. All continents have reported the disease, although a majority of cases are seen in North and South America, especially Peru. Balamuthia mandrillaris is a free living amoeba that can be isolated from soil. In published reported cases from North America, most patients will debut with neurological symptoms, where as in countries like Peru, a skin lesion will precede neurological symptoms. The classical cutaneous lesionis a plaque, mostly located on face, knee or other body parts. Diagnosis requires a specialized laboratory and clinical experience. This Amoebic encephalitis may be erroneously interpreted as a cerebral neoplasm, causing delay in the management of the infection. Thediagnosis of this infection has proven to be difficult and is usually made post-mortem but in Peru many cases were pre-morten. Despite case fatality rates as high as > 98%, some experimental therapies have shown protozoal therapy with macrolides and phenothiazines.
    [Show full text]
  • 3-Treatment of Dysentery and Amoebiasis .Pdf
    Treatment of dysentery and amoebiasis Objectives: 1. To understand different causes of dysentery. 2. To describe different classes of drugs used in treatment of both bacillary dysentery and amebic dysentery. 3. To be able to describe actions, side effects of drugs for treating bacillary dysentery. 4. To understand the pharmacokinetics, actions, clinical applications and side effects of antiamebic drugs. 5. to be able to differentiate between types of antiamebic drugs; luminal amebicides, and tissue amebicide. Editing File Color index: Important Note Extra Mind Maps Mnemonics Metronidazole اﻟﻤﯿﺘﻮ ﯾﻤﺸﻲ ﻻﻣﺎﻛﻦ ﺑﻌﯿﺪه ﻓﯿﺼﯿﺮ ﻧﺴﺘﺨﺪم ھﺬا اﻟﺪرق ﻓﻲ( Metro → systemic amoebicides( trophozoites - ﻧﺪى ﻗﺮﯾﯿﯿﺐ ﻣﻦ DNA ﻓﮭﻮ ﯾﺴﻮي اﻧﮭﺒﺖ ﻟﺪي ان اي رﯾﺒﻠﯿﻜﯿﺸﻦ → Nida - ﺟﺎﯾﮫ اﺣﺎول اﺻﯿﺮ طﺒﯿﺒﺔ اﺳﻨﺎن ﺑﺲ ﻗﺎﻟﻮا ﻟﻲ ﺑﻮو ﯾﺎ ﻛﺬاﺑﮫ !Clinical uses : Gia tri pu pseudo - .giardiasis → (ﺟﺎﯾﮫ) Gia - .trichomoniasis → (اﺣﺎول) Tri - طﺒﯿﺒﺔ أﺳﻨﺎن → ﯾﺴﺘﺨﺪم ﻓﻲ اﻟﺪﯾﻨﺘﺎل ﺑﺮاﻛﺘﺲ- .peptic ulcer → (ﺑﻮ) Pu - pseudomembranous colitis → (ﻛﺬاﺑﮫ)Pseudo - ﻧﺪى طﺒﯿﺒﺔ اﺳﻨﺎن طﯿﺐ ؟ : ADRs- ﺣﻄﺖ اﻟﺴﯿﻜﺸﻦ وﺻﺎر اﻟﻔﻢ ﺟﺎااف (dry mouth) ﺛﻢ ﺣﻄﺖ اﻟﺒﻨﺞ وﺻﺎر طﻌﻤﮫ ﻣﻮ ﺣﻠﻮ (metallic taste ) ﻋﺎد ﻧﺪى ﻛﺜﺮت ﺑﻨﺞ وﻛﺎن ﯾﺤﺒﮫ اﻟﻔﻨﻘﻞ ﻟﯿﻦ ﺳﻮى ﻟﻲoral thrush وﺑﻌﺪ ﻣﻦ ﻛﺜﺮة اﻟﺒﻨﺞ داﺧﺖ اﻟﺒﯿﺸﻨﺖ وﺻﺎر ﻋﻨﺪھﺎ neurotoxicological effect وﻟﻼﺳﻒ اﻟﺒﯿﺸﺖ ﺑﻠﻌﺖ ﻧﺺ اﻟﺒﻨﺞ وطﻠﻊ ﻣﻊ اﻟﯿﻮرن (dysuria ) وﻻﻧﮭﺎ اﺧﺬت ﻛﺤﻮل ﻗﺒﻞ ﺗﺮوح ﻟﻠﺪﻛﺘﻮره ﻧﺪى ﺻﺎر ﻓﯿﮫ ﺗﻌﺎرض ﻣﻊ اﻟﺒﻨﺞ اﻟﻠﻲ ﺑﻠﻌﺘﮫ (disulfiram like effect) . Emetine وﺣﺪه ﻣﻮﺻﯿﮫ اﺧﺘﮭﺎ ﺗﺠﯿﺐ ﻟﮭﺎ ﺑﺮوﺗﯿﻦ ﺑﺎر ، طﻮﻟﺖ اﺧﺘﮭﺎ ودﻗﺖ ﻋﻠﯿﮭﺎ ﻗﺎﻟﺖ اﻣﺘﺎ ﺗﺠﯿﻦ طﻮﻟﺘﻲ ؟ (emetine) ﻗﺎﻟﺖ اﺧﺘﮭﺎ ﻣﺎرااح اﺟﻲ وﻣﺎﻓﯿﮫ ﺑﺮوﺗﯿﻦ ﺑﺎر ، ﻓﺎﯾﺸﯿﺴﻮي
    [Show full text]
  • Entamoeba Histolytica - Wikipedia, the Free Encyclopedia • Ten Things You May Not Know About Wikipedia • 23,333 Have Donated
    Entamoeba histolytica - Wikipedia, the free encyclopedia • Ten things you may not know about Wikipedia • 23,333 have donated. You can help Wikipedia change the world! » Donate now! "So that others may enjoy the gift of knowledge" — Anon. [Hide this message] Entamoeba histolytica From Wikipedia, the free encyclopedia Jump to: navigation, search Entamoeba histolytica Entamoeba histolytica cyst Scientific classification Domain: Eukaryota Phylum: Amoebozoa Class: Archamoebae Genus: Entamoeba Species: E. histolytica For the infection and disease caused by this parasite, refer to Amoebiasis. Entamoeba histolytica is an anaerobic parasitic protozoan, part of the genus Entamoeba. It infects predominantly humans and other primates. It is estimated that about 50 million people are infected with the parasite worldwide. Diverse mammals such as dogs and cats can become infected but are not http://en.wikipedia.org/wiki/Entamoeba_histolytica (1 of 5)13/11/2550 13:08:05 Entamoeba histolytica - Wikipedia, the free encyclopedia thought to contribute significantly to transmission. The active (trophozoite) stage exists only in the host and in fresh loose feces; cysts survive outside the host in water, soils and on foods, especially under moist conditions on the latter. When cysts are swallowed they cause infections by excysting (releasing the trophozoite stage) in the digestive tract. E. histolytica, as its name suggests (histo–lytic = tissue destroying), causes disease; infection can lead to amoebic dysentery or amoebic liver abscess. Symptoms can include fulminating dysentery, diarrhea, weight loss, fatigue, abdominal pain, and amebomas. The amoeba can actually 'bore' into the intestinal wall, causing lesions and intestinal symptoms, and it may reach the blood stream. From there, it can reach different vital organs of the human body, usually the liver, but sometimes the lungs, brain, spleen, etc.
    [Show full text]
  • Amoebic Colitis Presenting As Colonic Perforation with Peritonitis
    ACS Case Reviews in Surgery Vol. 2, No. 2 Amoebic Colitis Presenting as Colonic Perforation with Peritonitis AUTHORS: CORRESPONDENCE AUTHOR: AUTHOR AFFILIATIONS: Kunal Chowdharya; Abhimanyu Sharmab; Gurinder Dr. Muzzafar Zaman a. Department of Surgery, MMIMSR – Assistant Kaurc; Aliya Shahd; Muzzafar Zamana; Rahul Department of Surgery Professor Yadave; Ashish Chowdharye; Ashutosh Bawae MMIMSR, Mullana,Ambala b. Department of Pathology, MMIMSR – Senior Haryana 133207 Resident India c. Department of Anaesthesia, MMIMSR – [email protected] Postgraduate Student d. Department of Microbiology, MMIMSR – Postgraduate Student e. Department of Surgery, MMIMSR – Postgraduate Student Background An 80-year-old male patient presented to the emergency department with complaints of abdominal pain with distension and obstipation that began two days prior to presentation. Summary The patient presented with sudden-onset pain in the abdomen and no passage of stool or flatus for two days. Clinical findings of peritonitis prompted rapid resuscitation and preparation for operation. Laparotomy via a midline vertical incision was performed. Generalized peritonitis with perforation of the right colon near the cecum was discovered. Right hemicolectomy with diverting ileostomy was performed. Peritoneal irrigation was done. Pathologic examination revealed ameboma with perforation. Conclusion Amoebiasis and its complications continue to be a public health problem in developing countries. Cecal perforation may spread to the appendix and lead to gangrenous appendicitis, and these patients should receive intensive medical and surgical management. Even with aggressive management, these patients have poor prognoses. Resection with exteriorization of the bowel is the current recommended treatment in such cases. Keywords Amoebiasis, colon, perforation peritonitis, laparotomy DISCLOSURE: The authors have no conflicts of interest to disclose.
    [Show full text]
  • Fulminant Amoebic Colitis in the Era of Computed Tomography Scan: a Case Report and Review of the Literature
    SA Journal of Radiology ISSN: (Online) 2078-6778, (Print) 1027-202X Page 1 of 4 Case Report Fulminant amoebic colitis in the era of computed tomography scan: A case report and review of the literature Authors: Amoebic colitis, caused by ingestion of water or food contaminated with the protozoan 1 Suman Mewa Kinoo Entamoeba histolytica, can progress to a fulminant colitis. Computed tomography (CT) Vikesh V. Ramkelawon2 Jaynund Maharajh3 findings reported in the literature on this type of colitis are sparse. We present a 59-year-old Bugwan Singh1 male patient with a one-week history of progressive abdominal pain, abdominal distension and associated watery and bloody diarrhoea. A CT scan revealed deep ulcerations with Affiliations: submucosal and intramural tracking of contrast. Colonoscopy and biopsy confirmed a 1Department of Surgery, University of KwaZulu-Natal, diagnosis of Amoebic colitis. The patient required a laparotomy and demised. Deep ulcerations King Edward VIII Hospital, with submucosal and intramural tracking of contrast on CT are diagnostic of fulminant Durban, South Africa amoebic colitis. Although not demonstrated at CT in this case, discontinuous bowel necrosis, omental wrapping (seen at laparotomy in our case) and neovascularisation of the bowel wall 2 Ethekwini Hospital and Heart may be other features to look out for. Centre, Durban, South Africa 3Department of Radiology, University of KwaZulu-Natal, Introduction King Edward VIII Hospital, Durban, South Africa Fulminant amoebic colitis (FAC) is the transmural extension of amoebic colitis, associated with a devastating outcome. Until a few decades ago, the diagnosis of FAC was made without the Corresponding author: recourse to computed tomography (CT) scan; diagnosis was largely clinically supported by stool Suman Mewa Kinoo, examination and sigmoidoscopic examination, with plain radiology and sonography having a [email protected] subsidiary diagnostic role.
    [Show full text]
  • Unique Features of Entamoeba Sulfur Metabolism; Compartmentalization, Physiological Roles of Terminal Products, Evolution and Pharmaceutical Exploitation
    International Journal of Molecular Sciences Review Unique Features of Entamoeba Sulfur Metabolism; Compartmentalization, Physiological Roles of Terminal Products, Evolution and Pharmaceutical Exploitation Fumika Mi-ichi * and Hiroki Yoshida Division of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-952-34-2294 Received: 30 August 2019; Accepted: 19 September 2019; Published: 21 September 2019 Abstract: Sulfur metabolism is essential for all living organisms. Recently, unique features of the Entamoeba metabolic pathway for sulfated biomolecules have been described. Entamoeba is a genus in the phylum Amoebozoa and includes the causative agent for amoebiasis, a global public health problem. This review gives an overview of the general features of the synthesis and degradation of sulfated biomolecules, and then highlights the characteristics that are unique to Entamoeba. Future biological and pharmaceutical perspectives are also discussed. Keywords: amoebiasis; mitosome; lipid metabolism; encystation; lateral gene transfer 1. Introduction 1.1. Sulfur Metabolism Sulfur is an essential element for life in all living organisms. Sulfate in the environment is typically activated as a prerequisite step for both sulfation and sulfate assimilation pathways. Sulfate activation is broadly found throughout the Bacteria, Protista, Fungi, Plantae, and Metazoa kingdoms [1,2]; KEGG (see Box1). Box 1. Databases. Sulfur metabolism research has greatly benefited from ever-expanding databases, such as the Kyoto Encyclopedia of Genes and Genomes (KEGG) (https://www.genome.jp/kegg/), The National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/), and AmoebaDB (https://amoebadb.org/ amoeba/).
    [Show full text]
  • CPG AID Full Version.Pdf
    Participating Professional Medical Societies and Agencies Department of Health San Lazaro Hospital Philippine Society for Microbiology and Infectious Diseases Philippine Society for Pediatric Nephrology Pediatric infectious Pediatric Gastroenterology, Society of the Disease Society of the Hepatology and Nutrition Philippines Philippines Philippine Society of Philippine Society of Philippine Academy Gastroenterology Nephrology of Family Physicians The CPG on the Management of Acute Infectious Diarrhea in Children and Adults was developed with funding from: Department of Health San Lazaro Hospital Philippine Society for Microbiology and Infectious Diseases https://www.psmid.org.ph/ 1 Contents Foreword 3 Acknowledgement 4 Acronyms 7 Part 1 Introduction 8 I. Background 10 II. The Philippine Profile 11 a. Morbidity and mortality rates of specific FWBDs 12 b. Outbreaks due to FWBDs 13 III. Development of Clinical Practice Guideline 16 Part 2 Clinical Practice Guidelines 19 I. Diagnosis 21 a. When is the diagnosis of acute infectious diarrhea suspected? 21 b. What pre-treatment clinical evaluations are recommended for immunocompetent patients presenting with acute infectious diarrhea? 22 c. What is the clinical use of diagnostic tests in children and adults with acute infectious diarrhea? 25 d. What are the clinical parameters that would indicate presence of dehydration in children with acute infectious diarrhea? 29 e. What are the clinical and laboratory parameters indicative of dehydration in adults with acute infectious diarrhea? f. What laboratory test should be done to assess for the presence of complications of acute infectious diarrhea? g. What is the role of colonoscopy in the evaluation of acute infectious diarrhea In adult and pediatric patients? II.
    [Show full text]
  • Amoebiasis in Active Ulcerative Colitis: Epidemiological Aspects, Association and Impact of Anti-Amoebic Therapy on Disease Severity
    Research Article Adv Res Gastroentero Hepatol Volume 15 Issue 1 - March 2020 DOI: 10.19080/ARGH.2020.15.555899 Copyright © All rights are reserved by Elham Ahmed Hassan Amoebiasis in Active Ulcerative Colitis: Epidemiological Aspects, Association and Impact of Anti-Amoebic Therapy on Disease Severity Elham Ahmed Hassan1*, Amany Mohamed Abdel-Hamed1, Saad Zaky Mahmoud1, Mohamed EM Tolba2, Asmaa Omar Ahmed3, Zainab Gaber Mahran1 1Gastroenterology and Tropical Medicine Department, Assiut University, Egypt 2Medical Parasitology Department, Assiut University, Egypt 3Clinical Pathology Department, Assiut University, Egypt Submission: Published: *Corresponding February author: 27, 2020; March 11, 2020 Elham Ahmed Hassan, MD, Department of Gastroenterology and Tropical Medicine, Al-Rajhi liver center, Assiut University Hospital, Assiut 71515, Egypt Abstract Background and Aim: Entamoeba (E.) thehistolytica incidence of ulcerative colitis (UC) is increasing worldwide. Several enteropathogens may be implicated in its pathogenesis. Amoebiasis is a common infection but it is overlooked or neglected especially in endemic regions. The study aimed to assess the frequencyPatients of and Methods in patients with active UC and evaluate the impact of the parasite and its therapy onE. diseasehistolytica severity. E. histolytica : Fresh fecal samples of 30 patients with active UC were examined for direct detection of cysts or trophozoites and its specific Ag ( II) using ELISA. Colonoscopy and assessment of UC severity based on Mayo score and Montreal ClassificationResults: were done. Patients with amoebiasis received anti-amoebic therapy and were followed up for 2 weeks. About 36.7% of those patients had amoebiasis. Amoebic infection was significantly higher in older age (P=0.048) and those with co-morbidities (P=0.001).
    [Show full text]